Colombia takes on cancer: first CAR-T trial for relapsed blood cancers
Disease control
Not yet recruiting
This study aims to bring a cutting-edge cancer treatment, CAR-T cell therapy, to Colombia for the first time. It will test the safety of a locally produced CAR-T product in 12 adults with certain relapsed or treatment-resistant blood cancers, such as lymphoma and leukemia. The st…
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC